These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1467532)

  • 1. Trial of recombinant human erythropoietin: three patients with thalassemia intermedia.
    Olivieri NF; Freedman MH; Perrine SP; Dover GJ; Sheridan B; Essentine DL; Nagel RL
    Blood; 1992 Dec; 80(12):3258-60. PubMed ID: 1467532
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial.
    Rachmilewitz EA; Goldfarb A; Dover G
    Blood; 1991 Aug; 78(4):1145-7. PubMed ID: 1868247
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human erythropoietin trial in thalassemia intermedia.
    Nişli G; Kavakli K; Vergin C; Oztop S; Cetingül N
    J Trop Pediatr; 1996 Dec; 42(6):330-4. PubMed ID: 9009557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum transferrin receptor levels in patients with thalassemia intermedia during rHuEPO administration.
    Dore F; Bonfigli S; Gaviano E; Pardini S; Longinotti M
    Haematologica; 1996; 81(1):37-9. PubMed ID: 8900849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum erythropoietin levels in thalassemia intermedia.
    Dore F; Bonfigli S; Gaviano E; Pardini S; Cianciulli P; Papa G; Longinotti M
    Ann Hematol; 1993 Oct; 67(4):183-6. PubMed ID: 8218539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antierythropoietin antibodies in thalassemia patients.
    Voulgari PV; Chaidos A; Tzouvara E; Alymara V; Alamanos Y; Drosos AA; Bourantas KL
    Ann Hematol; 2004 Jan; 83(1):22-7. PubMed ID: 14530877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of mouse beta-thalassemia by recombinant human erythropoietin.
    Leroy-Viard K; Rouyer-Fessard P; Beuzard Y
    Blood; 1991 Sep; 78(6):1596-602. PubMed ID: 1884025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between erythropoietin and iron metabolism in anaemia of chronic disorders.
    Vreugdenhil G; Nieuwenhuizen C; Swaak AJ
    Eur J Haematol; 1992 Jan; 48(1):56-7. PubMed ID: 1730281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with recombinant human erythropoietin in children with malignancies.
    Bolonaki I; Stiakaki E; Lydaki E; Dimitriou H; Kambourakis A; Kalmantis T; Kalmanti M
    Pediatr Hematol Oncol; 1996; 13(2):111-21. PubMed ID: 8721025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young β-thalassemia intermedia patients.
    Elalfy MS; Adly AA; Ismail EA; Elhenawy YI; Elghamry IR
    Eur J Haematol; 2013 Dec; 91(6):522-33. PubMed ID: 23927461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin.
    Major A; Mathez-Loic F; Rohling R; Gautschi K; Brugnara C
    Br J Haematol; 1997 Aug; 98(2):292-4. PubMed ID: 9266922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A favourable effect of recombinant human erythropoietin in three cases of leukaemic transformation from chronic myelomonocytic leukaemia.
    Uziel L; Fabrizi I; Zighetti ML; Carpani G; Rosti A; Moroni GA; Marmont A
    Br J Haematol; 1992 Feb; 80(2):260-2. PubMed ID: 1550789
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan.
    Hayashi J; Kumon K; Takanashi S; Kawashima Y; Eguchi S; Takaku F; Yamamura H
    Transfusion; 1994 Feb; 34(2):142-6. PubMed ID: 8310485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study.
    Di Raimondo F; Longo G; Cacciola E; Milone G; Palumbo GA; Cacciola RR; Alessi M; Giustolisi R
    Eur J Haematol; 1996; 56(1-2):7-11. PubMed ID: 8599997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study.
    Breymann C; Major A; Richter C; Huch R; Huch A
    J Perinat Med; 1995; 23(1-2):89-98. PubMed ID: 7658327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin for treatment of myelodysplastic syndromes.
    Rafanelli D; Grossi A; Longo G; Vannucchi AM; Bacci P; Ferrini PR
    Leukemia; 1992 Apr; 6(4):323-7. PubMed ID: 1588794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted serum erythropoietin response to anemia in patients polytransfused for beta-thalassemia major.
    Chen JS; Lin KH; Wang ST; Tsao CJ; Yeh TF
    J Pediatr Hematol Oncol; 1998; 20(2):140-4. PubMed ID: 9544165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.